Fatty liver disease (MASLD/MASH) trials in Taiwan
18 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
- Where
- Changhua, Kaohsiung City, Taichung, Tainan, Taipei City, Taoyuan
- Age
- 18 years to 80 years
- People
- 1,650 worldwide
- Run by
- Akero Therapeutics, Inc
See details and how to joinNCT06215716 - Phase 3Taking peopleLIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
- Where
- Changhua, Kaohsiung City, Kaohsuing City, Taichung, Tainan, Taipei, Taoyuan
- Age
- 18 years and over
- People
- 1,800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06632444 · EU 2024-513739-25-00 - Phase 3Taking peopleLIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
- Where
- Changhua, Kaohsuing City, Taichung, Tainan, Taipei, Taoyuan
- Age
- 18 years and over
- People
- 1,590 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT06632457 · EU 2024-513741-36-00 - Phase 3Taking peopleA Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- Where
- Chiayi City, Kaohsiung City, Taipei
- Age
- 18 years to 80 years
- People
- 1,350 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06318169 · EU 2023-509912-27-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- Where
- Chiayi City, Kaohsiung City, Tainan
- Age
- 18 years to 75 years
- People
- 1,800 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT06419374 · EU 2023-510395-31-00 - Phase 3Taking peopleA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- Where
- Chiayi City, Kaohsiung City, Kaohsiung Niao Sung Dist, New Taipei City, Taichung, Tainan, Taipei, Taoyuan
- Age
- 18 years and over
- People
- 4,500 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07165028 · EU 2025-522674-36-00 - No phaseEnrolling by invitationA Prospective Cohort Study on Patient With Obesity Undergoing Weight Change
- Where
- Taipei
- Age
- 18 years and over
- People
- 500
- Run by
- National Taiwan University Hospital
See details and how to joinNCT07239167 - Phase 3Taking peopleA Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
- Where
- Chiayi City, Kaohsiung City
- Age
- 18 years to 75 years
- People
- 1,200 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07221227 - No phaseTaking peopleTaiwan Green Propolis for Blood Lipids and Body Fat in Patients With MASLD
- Where
- Dalin
- Age
- 18 years to 80 years
- People
- 60
- Run by
- Taipei Medical University
See details and how to joinNCT07692438 - No phaseTaking peopleThe Evaluation of Orange Peel Fermentation on Body Fat Lowering Efficacy in Adults
- Where
- Taipei
- Age
- 20 years to 65 years
- People
- 124
- Run by
- TCI Co., Ltd.
See details and how to joinNCT04496895 - No phaseTaking peopleImpact of a Probiotic Supplementation With Lifestyle Modification on Liver Steatosis, Fibrosis, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
- Where
- New Taipei City
- Age
- 18 years to 80 years
- People
- 80
- Run by
- Fu Jen Catholic University Hospital
See details and how to joinNCT07400367 - Phase 3Taking peopleUsing Hydroxychloroquine (HCQ) to Treat Steatohepatitis
- Where
- Taipei
- Age
- 18 years and over
- People
- 210
- Run by
- National Taiwan University Hospital
See details and how to joinNCT07265297 - No phaseTaking peopleValidating Integrative Multi-omics Approaches in Metabolic Syndrome-related Diseases
- Where
- Taoyuan
- Age
- 20 years and over
- People
- 6,266
- Run by
- Chang Gung Memorial Hospital
See details and how to joinNCT07248371 - Phase 2Taking peopleStudy of ADI-PEG 20 Versus Placebo in Subjects With NASH
- Where
- Chiayi City, Kaohsiung, Keelung, Tainan, Taipei, Taoyuan
- Age
- 18 years to 80 years
- People
- 60
- Run by
- Polaris Group
See details and how to joinNCT05842512 - No phaseTaking peopleLiver Disease and Other Systemic Diseases
- Where
- New Taipei City
- Age
- 18 years to 99 years
- People
- 15,000
- Run by
- Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
See details and how to joinNCT04525833 - No phaseNot yet taking people in TaiwanStudy on the Function of Taiwan Green Propolis in Reducing Blood Lipids and Body Fat in Sub-healthy Groups: MASLD
- Where
- Chiayi City
- Age
- 18 years to 80 years
- People
- 60
- Run by
- Kuo,HSIN-YU
See details and how to joinNCT07114926 - No phaseTaking peopleDevelopment of Microbial Therapeutics for Metabolic-associated Fatty Liver Disease: From Mechanistic Investigations to Clinical Trials
- Where
- Taipei
- Age
- 18 years to 70 years
- People
- 40
- Run by
- National Taiwan University Hospital
See details and how to joinNCT06873165 - No phaseEnrolling by invitationChronic Hepatitis B Patients With Concurrent MAFLD: Cohort Study and Exercise Intervention.
- Where
- Taipei
- Age
- 18 years to 70 years
- People
- 100
- Run by
- National Taiwan University Hospital
See details and how to joinNCT05956379